Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2005
10/06/2005US20050221318 Building block forming a c-c bond upon reaction
10/06/2005US20050221317 Use of an epitope of vascular endothelial growth factor receptor kdr/flk-1
10/06/2005US20050221314 Method and device for determination of tissue specificity of free floating dna in bodily fluids
10/06/2005US20050221313 Methods of identifying gene expression products resultant from alternative splicing and methods of diagnosing and treating disorders associated therewith
10/06/2005US20050221309 Method for the diagnosis of lymphoproliferative diseases
10/06/2005US20050221308 Protein tag comprising a biotinylation domain and method for increasing solubility and determining folding state
10/06/2005US20050221305 Antigen panels and methods of using the same
10/06/2005US20050221303 Sequences involved in phenomena of tumour suppression, tumour reversion, apoptosis and/or virus resistance and their use as medicines
10/06/2005US20050221300 Diagnostic assays for parvovirus B19
10/06/2005US20050221299 Peptide from the glycoprotein B from human herpesvirus 7 for use in a serological ELISA test
10/06/2005US20050221297 Diagnostic reagent for hepatitis C virus infection
10/06/2005US20050221296 Comprises peptide for genotyping and detecting hepatitis viral infection; immunoassay; antigenic peptides of HCV immobilized on solid substrate
10/06/2005US20050221295 Peptides from the E7 protein of human papilloma viruses 16 and 18 for detecting and/or diagnosing cervical and other human papilloma virus associated cancers
10/06/2005US20050221287 Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs53 upregulation
10/06/2005US20050221286 Protease assay for therapeutic drug monitoring
10/06/2005US20050221284 Heteropolymer complexes and methods for their use
10/06/2005US20050221283 Biochip
10/06/2005US20050221282 comprising biological membrane and porous or perforated substrate, capable of adhering with high resistance seals to substrate such perforated glass, forming sheets having ion channel or transporter; bioassay; drug screening; microtiter plates
10/06/2005US20050221280 Profiling chemical compounds to improve drug safety and efficacy at an early stage in drug development
10/06/2005US20050221279 Method for creating chemical sensors using contact-based microdispensing technology
10/06/2005US20050221278 Method for determining metabolic flux
10/06/2005US20050221274 "Ussing chamber" apparatus; plurality of dual-compartment assay chambers where compartments of each chamber are separated by a cell layer across which ions can flow; use in functional analysis of ion transport proteins in both basic research and drug discovery
10/06/2005US20050221273 Method for detecting diseases that are associated with defects of cystic fibrosis transmembrane conductance regulator (cftr)protein
10/06/2005US20050221272 Obtaining a cell that expresses a fusion protein containing a glutamine-rich polypeptide and a fluorescent polypeptide; exposing the cell to a compound; incubating the cell, measuring second fluorescence emission
10/06/2005US20050221271 Substrates, devices, and methods for cellular assays
10/06/2005US20050221270 Process for identifying and treating cells types within a living organism
10/06/2005US20050221081 Stabilization of self-assembled monolayers
10/06/2005US20050220815 Method of measuring the duration of adequate immune memory in companion animals
10/06/2005US20050220812 Screening process
10/06/2005US20050220811 Identification of virulence associated regions rd1 and rd5 leading to improve vaccine of m. bovis bcg and m. microti
10/06/2005US20050220809 Nucleotide sequence coding for a tolc and a defined amino acid sequence
10/06/2005US20050220807 Methods of delivery of exogenous proteins to the cytosol and uses thereof
10/06/2005US20050220805 Polynucleotide sequence for Chalmydia pneumonia; therapy, prevention of Chlamydia infections ; vaccines
10/06/2005US20050220804 Increasing an immune response in an animal, comprising administering a compound (such as a carbohydrate, an antibiotic, a sugar, a protein, or an antibody) that binds a C-type lectin (but not the DEC-205 receptor) on the surface of a dendritic cell
10/06/2005US20050220800 Cytokines and cytokine receptors with reduced immunogenicity
10/06/2005US20050220798 Cancer-linked gene as target for chemotherapy
10/06/2005US20050220796 Compositions and methods for modulating DNA repair
10/06/2005US20050220795 Complementarity determining regions which bind to catalytic domain of aspartyl (asparaginyl) beta -hydroxylase; diagnosis and treatment of cancer; readily penetrates tumors, no side effects, less toxic
10/06/2005US20050220790 Amino-terminally truncated rantes as chemokine antagonists
10/06/2005US20050220788 Use of molecules which interact with the haptoglobin receptor ligand binding
10/06/2005US20050220762 Modified human interferon polypeptides and their uses
10/06/2005US20050220712 Method for determining mucosal neutrophil counts in neutropenia patents
10/06/2005US20050220710 Overfeeding methods for determining therapeutic strategies and/or targets for obesity therapeutics
10/06/2005US20050220709 Which causes apoptosis in T-lymphocytes; determining the concentration of 6-thioguanosine diphosphate and 6-thioguanosine triphosphate in a red blood cell sample; Chron's Disease, ulcerative colitis; inhibition of bcl-xL mRNA and protein expression, NF- kappa B p50/p65 activation, kappa B phosphorylation
10/06/2005US20050220707 piperazine(piperidine)carboxamidine; antidepressant, brain trauma, ischemia, stroke, neurodegenerative disorders, opioid addiction, idiopathic pain, epilepsy; varying activities on nitric oxide synthases (NOS), arginine decarboxylases (ADC), and nitrosodimethylamine (NDMA) receptor binding
10/06/2005US20050220706 Tyrosine kinase type 1 family of receptors; cancer imaging or therapeutic agent targeting to malignant cells ErbB-2 receptor
10/06/2005US20050220675 High density plate filler
10/06/2005US20050220673 Sensor comprising an array of pieroresistors
10/06/2005US20050220629 Method of segregating a bolus of fluid using a pneumatic actuator in a fluid handling circuit
10/06/2005US20050220169 Monitoring device
10/06/2005US20050219527 Sample analyzer and computer program product
10/06/2005US20050219508 Flow cytometer for classifying leukocytes and method for determining detection angle range of the same
10/06/2005US20050218464 Biochemical ultrasensitive charge sensing
10/06/2005US20050218244 Soil moisture content measurement system and method
10/06/2005US20050218205 Validating competition entry
10/06/2005US20050217750 Method and apparatus for gradient generation
10/06/2005US20050217587 Device for and a method of detecting a disease of the udder of an animal
10/06/2005US20050217387 Toner evaluation method, toner cartridge, and image forming apparatus
10/06/2005US20050217382 Methods for quantitatively determining lengthwise shrinkage in wood products
10/06/2005US20050217370 Outer casing for gas sensor
10/06/2005US20050217349 System and method for simulating lubricating oil testing
10/06/2005DE10217415B4 Poröser Film mit einem Funktionskörper auf Basis von Cellulosenitrat mit hydrophilen Eigenschaften, dessen Verwendung und Verfahren zu seiner Herstellung A porous film having a functional body on the basis of cellulose nitrate with hydrophilic properties, its use and process for its preparation
10/06/2005DE102005013298A1 Steuervorrichtung für einen Gassensor A control device for a gas sensor
10/06/2005DE102004027024A1 Fleischverarbeitungsmaschine mit Fettanalysevorrichtung Meat processing machine with fat analyzer
10/06/2005DE102004022298A1 Test kit for enzyme immunoassay identification of human cathepsin K, in blood and other body fluids, has separate packages containing antibodies bonded to micro-titration plates, standard human recombinant cathepsin K and buffers
10/06/2005DE102004013155A1 Biopsy needle, with a sample taking section, comprises a longitudinal cutter with a corrugated cutting edge for a sample to be cut by a to-and-fro or a rotary movement
10/06/2005DE102004012672A1 Messfühler Probe
10/06/2005DE10101679B4 Flüssigkeitstestvorrichtung Fluid testing device
10/06/2005DE10018508B4 Verfahren zur sensorischen Erfassung und Berechnung bzw. Simulation der Ausbreitung von Gerüchen A method for sensory detection and calculation or simulation of the propagation of odors
10/06/2005DE10018506B4 Einrichtung zur sensorischen Erfassung und Berechnung bzw. Simulation der Ausbreitung von Gerüchen Means for sensory detection and calculation or simulation of the propagation of odors
10/06/2005CA2602957A1 Sampling single phase from multiphase fluid
10/06/2005CA2597409A1 Biological dataset profiling of asthma and atopy
10/06/2005CA2568935A1 Inactive ca2+/calmodulin-dependent protein kinase ii.alpha. knockin animal and knockin cell of the same
10/06/2005CA2564989A1 Reducing the risk of human and anti-human antibodies through v gene manipulation
10/06/2005CA2561511A1 Method of monitoring microbe causing infectious disease of experimental animal
10/06/2005CA2561502A1 Marker gene for arthrorheumatism test
10/06/2005CA2561495A1 Truncated dance, dance complex and method of using these
10/06/2005CA2561286A1 A diagnostic method for stroke/asymptomatic cerebal infarction using polyamine or acrolein content, polyamine oxidase activity or protein content thereof as an indicator
10/06/2005CA2561246A1 Method of detecting conformational change of an amyloid protein, a method of searching a substance having an activity that affects to conformational change of an amyloid protein, and a method of searching a therapeutic or diagnostic agent for amyloid-related diseases
10/06/2005CA2561192A1 Cancerous disease modifying antibodies
10/06/2005CA2560869A1 Treatment of neurodegenerative diseases by the use of laptm4b
10/06/2005CA2560864A1 Cytotoxicity mediation of cells evidencing surface expression of cd63
10/06/2005CA2560862A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp
10/06/2005CA2560859A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
10/06/2005CA2560835A1 Methods for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses
10/06/2005CA2560696A1 Mutations of the pik3ca gene in human cancers
10/06/2005CA2560526A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
10/06/2005CA2559943A1 Cell concentration and pathogen recovery
10/06/2005CA2559867A1 Method for screening agents modulating a lkb$g(a) protein ubiquitination and means for carrying out said method
10/06/2005CA2559480A1 Methods and compositions for inhibition of metastasis
10/06/2005CA2558357A1 Labelling reagents, methods for the synthesis of such reagents and methods for the detection of biological molecules
10/06/2005CA2558124A1 Chemokine ccl18 as a biomarker
10/06/2005CA2557677A1 In vitro test system for predicting patient tolerability of therapeutic agents
10/06/2005CA2556221A1 Development and use of fluorescent probes of unbound analytes
10/05/2005EP1583018A1 Method for determining metabolic flux
10/05/2005EP1582873A1 Method of diagnosing non-alcoholic steatohepatitis (nash) using molecular markers
10/05/2005EP1582872A1 Method of analyzing c-terminal amino acid sequence of peptide
10/05/2005EP1582871A1 Composition containing particle surface charge control agent, particle separating method using same, particle separator
10/05/2005EP1582870A1 Immunoassay method and kit to be used therein
10/05/2005EP1582869A2 Interrupted flow testing device and method for immunological confirmatory tests
1 ... 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 2041 2042 ... 3937